Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1241405-22-0

(2-fluoro-4-methylphenyl)acetaldehyde is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1241405-22-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1241405-22-0 Structure

  • Basic information

    1. Product Name: (2-fluoro-4-methylphenyl)acetaldehyde
    2. Synonyms: (2-fluoro-4-methylphenyl)acetaldehyde
    3. CAS NO:1241405-22-0
    4. Molecular Formula:
    5. Molecular Weight: 152.168
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1241405-22-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: (2-fluoro-4-methylphenyl)acetaldehyde(CAS DataBase Reference)
    10. NIST Chemistry Reference: (2-fluoro-4-methylphenyl)acetaldehyde(1241405-22-0)
    11. EPA Substance Registry System: (2-fluoro-4-methylphenyl)acetaldehyde(1241405-22-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1241405-22-0(Hazardous Substances Data)

1241405-22-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1241405-22-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,1,4,0 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1241405-22:
(9*1)+(8*2)+(7*4)+(6*1)+(5*4)+(4*0)+(3*5)+(2*2)+(1*2)=100
100 % 10 = 0
So 1241405-22-0 is a valid CAS Registry Number.

1241405-22-0Relevant articles and documents

Loxoprofen derivative

-

Paragraph 0035-0036; 0039, (2019/01/23)

The invention provides a Loxoprofen derivative. Gastrointestinal tract side effects are low, and the bioavailability can be improved.

LOXOPROFEN DERIVATIVE AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME

-

Page/Page column 3-4, (2012/02/01)

There is provided a novel loxoprofen derivative that has no side effect such as a gastrointestinal disorder and also has excellent anti-inflammatory and analgesic effects and is represented by the following formula (I) or (II): (wherein R1 and

Properties and synthesis of 2-{2-fluoro (or bromo)-4-[(2-oxocyclopentyl) methyl]phenyl}propanoic acid: Nonsteroidal anti-inflammatory drugs with low membrane permeabilizing and gastric lesion-producing activities

Yamakawa, Naoki,Suemasu, Shintaro,Matoyama, Masaaki,Kimoto, Ayumi,Takeda, Miho,Tanaka, Ken-Ichiro,Ishihara, Tomoaki,Katsu, Takashi,Okamoto, Yoshinari,Otsuka, Masami,Mizushima, Tohru

supporting information; experimental part, p. 7879 - 7882 (2011/02/22)

We previously proposed that membrane permeabilization activity of NSAIDs is involved in NSAID-induced gastric lesions. We here synthesized derivatives of loxoprofen that have lower membrane permeabilization activity than other NSAIDs. Compared to loxoprofen, the derivatives 10a and 10b have lower membrane permeabilization activity and their oral administration produced fewer gastric lesions but showed an equivalent anti-inflammatory effect. These results suggest that 10a and 10b are likely to be therapeutically beneficial as safer NSAIDs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1241405-22-0